Silexion Therapeutics Ltd. (SLXNW) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q1'21 |
|---|
| Cash from Operations | -3.65M | -3.02M | -2.84M | -2.51M | -2.45M | -2.93M | -2.65M | -1.06M | -1.75M | -5.02M | -685K | -13.97K | 531.83K | 660.3K | 354.55K | -57.86K | -140.56K | -373.46K | -805.18K |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | -48.63% | -3.08% | -7.16% | -135.4% | -40.01% | 41.74% | -287.3% | -7522.39% | -429.43% | -860.62% | -293.2% | 75.85% | 478.37% | 276.8% | - | - | 82.54% | - | - |
| Net Income | -2.73M | -4.41M | -3.26M | -2.5M | -1.74M | -1.75M | -11.86M | -1.49M | -1.42M | -1.73M | -809K | 162.95K | 313.19K | 494.41K | 292.58K | 42.69K | -245.66K | -241.77K | -97.75K |
| Depreciation & Amortization | 2K | 3K | 4K | 3K | 4K | -12K | 22K | 7K | 8K | 6K | 10K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 345K | 0 | 38K | 37K | 21K | 31.97K | 5.8M | 32K | 32 | 0 | 32K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 4K | 88K | -16K | 229K | 81K | -251.97K | 3.82M | 83K | 167.97K | -3.42M | 107K | -418 | -4.88K | 10.39K | -9.56K | -36.35K | -95.19K | -189.45K | 5.78K |
| Working Capital Changes | -1.26M | 1.3M | 393K | -273K | -824K | -947K | -430K | 302K | -505K | 123.68K | -25K | -176.5K | 223.52K | 155.49K | 71.53K | -64.2K | 200.29K | 57.75K | -713.21K |
| Change in Receivables | 0 | 0 | 16K | 0 | 4K | 0 | 0 | 2K | 0 | 0 | 24K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 65K | -57K | 254K | -30K | -207K | 131K | 517K | 37K | -75K | 0 | 131K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Investing | 0 | -7K | 0 | -1K | -6K | 0 | -16K | 0 | -6K | 573K | 72K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Expenditures | 0 | -2K | 0 | -1K | -6K | 0 | -16K | 0 | -6K | -12K | -6K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 78K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 507K | 78K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 83K | -221K | 8.62M | -195K | 7.43M | 2.18M | 2.92M | 0 | 0 | 112.12M | 0 | 535K | -90.37M | 190K | 350K | 60K | 290K | 300K | 116.1M |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | -696K | -250K | -505K | 0 | 0 | -1.3M | 0 | 535K | 385K | 190K | 350K | 60K | 290K | 300K | -149.99K |
| Equity Issued (Net) | 0 | -221K | 8.62M | -195K | 5M | 2.43M | 620K | 0 | 0 | 113.43M | 0 | 0 | -90.75M | 0 | 0 | 0 | 0 | 0 | 118.8M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 112.9M | 0 | 0 | -90.75M | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 83K | 0 | 0 | 0 | 3.13M | 0 | 2.81M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2.55M |
| Net Change in Cash | -3.58M | -3.25M | 5.78M | -2.69M | 4.96M | -753K | 276K | -1.08M | -1.81M | 4.56M | -679K | -36.97K | 11.79K | -142.62K | 184.53K | -161.2K | 140.06K | -75.64K | 294.99K |
| Free Cash Flow | -3.65M | -3.02M | -2.84M | -2.51M | -2.46M | -2.93M | -2.67M | -1.06M | -1.76M | -5.03M | -691K | -13.97K | 531.83K | 660.3K | 354.55K | -57.86K | -140.56K | -373.46K | -805.18K |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | -48.27% | -3.14% | -6.52% | -135.49% | -39.87% | 41.88% | -286.25% | -7523.48% | -430.56% | -862.44% | -294.89% | 75.86% | 478.37% | 276.81% | - | - | 82.54% | - | - |
| FCF per Share | -11.29 | -9.65 | -25.10 | -43.28 | -3.63 | -3.17 | -4.12 | -2.48 | -15.73 | -51.84 | -1.25 | -0.02 | 0.44 | 0.40 | 0.21 | -0.04 | -0.09 | -0.23 | -0.49 |
| FCF Conversion (FCF/Net Income) | 1.33x | 0.68x | 0.87x | 1.00x | 1.41x | 93.97x | 0.22x | 0.72x | 1.28x | 2.91x | 0.87x | -0.09x | -687.12x | 1.34x | 1.21x | -1.36x | 0.57x | 1.54x | 8.24x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |